Literature DB >> 11099853

Relative position of the hexahistidine tag effects binding properties of a tumor-associated single-chain Fv construct.

A Goel1, D Colcher, J S Koo, B J Booth, G Pavlinkova, S K Batra.   

Abstract

Hexahistidine tag (His-tag) is the most widely used tag for affinity purification of recombinant proteins for their structural and functional analysis. In the present study, single chain Fv (scFv) constructs were engineered form the monoclonal antibody (MAb) CC49 which is among the most extensively studied MAb for cancer therapy. For achieving efficient purification of scFvs by immobilized metal-ion affinity chromatography (IMAC), a His-tag was placed either at the C-terminal (scFv-His6) or N-terminal (His6-scFv) of the coding sequence. Solid-phase radioimmunoassay for scFv-His6 showed only 20-25% binding whereas both His6-scFv and scFv (no His-tag) showed 60-65% binding. Surface plasmon resonance studies by BIAcore revealed the binding affinity constant (KA) for His6-scFv and scFv as 1.19 x 10(6) M(-1) and 3.27 x 10(6) M(-1), respectively. No K(A) value could be calculated for scFv-His6 due to poor binding kinetics (kon and koff). Comparative homology modeling for scFv and scFv-His6 showed that the C-terminal position of the His-tag partially covered the antigen-binding site of the protein. The study demonstrates that the C-terminal position of His-tag on the CC49 scFv adversely affects the binding properties of the construct. The results emphasize the importance of functional characterization of recombinant proteins expressed with purification tags.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11099853     DOI: 10.1016/s0304-4165(00)00086-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  13 in total

1.  Molecular immunolabeling with recombinant single-chain variable fragment (scFv) antibodies designed with metal-binding domains.

Authors:  Marek Malecki; Annie Hsu; Lynn Truong; Sylvia Sanchez
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-26       Impact factor: 11.205

2.  Interactions between EB1 and microtubules: dramatic effect of affinity tags and evidence for cooperative behavior.

Authors:  Zhiqing C Zhu; Kamlesh K Gupta; Aranda R Slabbekoorn; Benjamin A Paulson; Eric S Folker; Holly V Goodson
Journal:  J Biol Chem       Date:  2009-09-23       Impact factor: 5.157

3.  Double trouble-Buffer selection and His-tag presence may be responsible for nonreproducibility of biomedical experiments.

Authors:  Karolina A Majorek; Misty L Kuhn; Maksymilian Chruszcz; Wayne F Anderson; Wladek Minor
Journal:  Protein Sci       Date:  2014-07-30       Impact factor: 6.725

4.  Influence of histidine tag attachment on picosecond protein dynamics.

Authors:  Megan C Thielges; Jean K Chung; Jun Y Axup; Michael D Fayer
Journal:  Biochemistry       Date:  2011-06-06       Impact factor: 3.162

5.  Anti-FLT3 nanoparticles for acute myeloid leukemia: Preclinical pharmacology and pharmacokinetics.

Authors:  Mincheol Park; Vijaya Pooja Vaikari; Albert T Lam; Yong Zhang; John Andrew MacKay; Houda Alachkar
Journal:  J Control Release       Date:  2020-05-16       Impact factor: 9.776

6.  Structural basis of an epitope tagging system derived from Haloarcula marismortui bacteriorhodopsin I D94N and its monoclonal antibody GD-26.

Authors:  Po-Jung Pao; Min-Feng Hsu; Ming-Hui Chiang; Chun-Ting Chen; Cheng-Chung Lee; Andrew H-J Wang
Journal:  FEBS J       Date:  2021-10-01       Impact factor: 5.622

7.  Anti-CD99 scFv-ELP nanoworms for the treatment of acute myeloid leukemia.

Authors:  Vijaya Pooja Vaikari; Mincheol Park; Lena Keossayan; J Andrew MacKay; Houda Alachkar
Journal:  Nanomedicine       Date:  2020-06-12       Impact factor: 5.307

8.  Comparative study of His- and Non-His-tagged CLIC proteins, reveals changes in their enzymatic activity.

Authors:  Daniel R Turkewitz; Saba Moghaddasi; Amani Alghalayini; Claudia D'Amario; Hala M Ali; Michael Wallach; Stella M Valenzuela
Journal:  Biochem Biophys Rep       Date:  2021-05-14

9.  Modifying an immunogenic epitope on a therapeutic protein: a step towards an improved system for antibody-directed enzyme prodrug therapy (ADEPT).

Authors:  A Mayer; S K Sharma; B Tolner; N P Minton; D Purdy; P Amlot; G Tharakan; R H J Begent; K A Chester
Journal:  Br J Cancer       Date:  2004-06-14       Impact factor: 7.640

10.  Characterization of native protein complexes and protein isoform variation using size-fractionation-based quantitative proteomics.

Authors:  Kathryn J Kirkwood; Yasmeen Ahmad; Mark Larance; Angus I Lamond
Journal:  Mol Cell Proteomics       Date:  2013-09-16       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.